Latest news

Insights

Is Green Biotech the Future of Sustainable Drug Development?

Executive Summary Yes—green biotech is emerging as a foundational pillar of sustainable drug development in 2026. The shift is not...
Commercial

Amgen Adds $300 Million to Puerto Rico Expansion, Bringing U.S. Investment Commitments Near $2 Billion

Amgen has announced an additional $300 million investment to expand its manufacturing operations in Puerto Rico, increasing its overall...
Clinical

Gedatolisib from Celcuity outperforms Piqray from Novartis in phase 3 research

A phase 3 trial of a pan-PI3K/mTOR inhibitor, Celcuity, has met its primary endpoint, and the biotech is now...
Clinical

Takeda Reports Phase 2/3 Data Showing TAK-881 Comparable to HyQvia in Primary Immunodeficiency Disease

Takeda has reported that its investigational therapy TAK-881 met the primary endpoint in a phase 2/3 clinical study, demonstrating...
Clinical

In a late-stage trial, Intellia’s gene treatment for rare condition reduces swelling attacks

Intellia Therapeutics has announced that its experimental gene-editing drug...
Clinical

Boehringer Reports Phase 3 Data on Survodutide Showing 16.6% Weight Loss at Week 76

Boehringer Ingelheim has reported results from a phase 3...
Regulatory

Revolution Challenges Erasca’s ERAS-0015 Over Patent and Data Comparison Claims

Revolution Medicines has raised legal and competitive concerns against Erasca following recent developments in pancreatic cancer drug research. The...
Manufacturing

Lilly and Profluent Sign Up to $2.25 Billion Collaboration to Develop AI-Designed Genetic Medicines

Eli Lilly has entered into a multi-program research collaboration with California-based Profluent to develop genetic medicines using artificial intelligence-designed...
Clinical

Novartis and PTC Advance Huntington’s Drug Votoplam to Phase 3 Following Mid-Stage Data

Novartis and PTC Therapeutics have moved their Huntington’s disease candidate, votoplam, into Phase 3 development after results from a...
Commercial

Chiesi to Acquire KalVista for $1.9 Billion, Adding Oral HAE Therapy Ekterly

Italy-based Chiesi Group has agreed to acquire KalVista Pharmaceuticals...
Commercial

Teva Pens Deal Worth Over $700M to Buy Emalex

Teva Pharmaceuticals has agreed to acquire Emalex Biosciences in...
Insights

Top 10 Pharma Companies Leading Innovation in Drug Development (2026)

Executive Summary Drug development in 2026 is undergoing a structural transformation driven by AI-enabled discovery, precision medicine, advanced biologics, and...
Uncategorized

Top 10 Emerging Trends in Life Sciences for 2026

Emerging Trends:Executive Summary The life sciences industry in 2026 is entering a phase of accelerated transformation, driven by the convergence...
Insights

Top 10 Breakthrough Therapies Shaping the Future of Medicine (2026)

Executive Summary The therapeutic landscape in 2026 is undergoing a fundamental transformation, driven by next-generation modalities, platform-based innovation, and precision...
Regulatory

Revolution Challenges Erasca’s ERAS-0015 Over Patent and Data Comparison Claims

Revolution Medicines has raised legal and competitive concerns against...
Editorial Team -

Popular

Most popular life news you must read today

View all articles

Commercial

Information Technology

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

Chugai Pharmaceutical has entered into a research collaboration with Singapore-based Gero to develop antibody-based...
Editorial Team -

J&J MedTech presents the first Ottava surgical robot clinical cases

Johnson & Johnson MedTech successfully conducted the initial clinical use of Ottava surgical robot...
Editorial Team -

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

Common conditions in women such as PCOS, menopause, and endometriosis often lead to hormonal...
Editorial Team -

PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm

Health technology company PicnicHealth has launched a new product, Virtual Site, which allows researchers...
Editorial Team -

Regulatory

Regulatory

Revolution Challenges Erasca’s ERAS-0015 Over Patent and Data Comparison Claims

Revolution Medicines has raised legal and competitive concerns against...
Editorial Team -
Commercial

Amgen Adds $300 Million to Puerto Rico Expansion, Bringing U.S. Investment Commitments Near $2 Billion

Amgen has announced an additional $300 million investment to...
Clinical

Gedatolisib from Celcuity outperforms Piqray from Novartis in phase 3 research

A phase 3 trial of a pan-PI3K/mTOR inhibitor, Celcuity,...
Clinical

Takeda Reports Phase 2/3 Data Showing TAK-881 Comparable to HyQvia in Primary Immunodeficiency Disease

Takeda has reported that its investigational therapy TAK-881 met...
Insights

Top 10 High-Impact Careers Defining the Future of Life Sciences

Executive Summary The life sciences workforce in 2026 is being...

Research & Development

Market Access

Manufacturing

U.S. Biopharma Companies Advance Over $370B in Manufacturing and R&D Investments

Major drugmakers have announced more than $370 billion in...
Manufacturing

Novartis Plans 550 Layoffs in Switzerland While Expanding U.S. Manufacturing Footprint

 550 Layoffs ;Novartis has outlined several updates to its...

Manufacturing & RegulatoryPOPULAR
Find Your Perfect Music Festival

Insights

Is Green Biotech the Future of Sustainable Drug Development?

Executive Summary Yes—green biotech is emerging as a foundational pillar...
Editorial Team -
Manufacturing

Avalyn Files for IPO Targeting Up to $209.7 Million to Advance Inhaled Lung Therapies

Avalyn Pharma, a Boston-based company focused on inhaled therapies...
Editorial Team -